メタ解析:抗高血圧薬の服従に対する薬物クラスの影響
Ian M Kronish1, Mark Woodward, Ziad Sergie
1Division of General Internal Medicine, Mount Sinai School of Medicine, New York, NY, USA. ian.kronish@mssm.edu
Circulation
|April 6, 2011
まとめ
血圧薬を服用する患者の順守は,薬剤のクラスによって異なります. アンジオテンシンII受容体阻害剤は,最も高いアデレンスを示し,利尿剤とベータブロッカーは最も低い値を示したが,全体的なアデレンスは最適以下である.
科学分野:
- 薬理学 薬理学とは
- クリニック薬局 臨床薬局
- 心血管医学 心血管医学
背景:
- 観察的研究は,異なる抗高血圧薬の薬剤クラスで異なるアデバーンス率を示しています.
- 抗高血圧薬のクラスと臨床実務における患者の遵守の間の関連を定量化することは極めて重要です.
研究 の 目的:
- 様々な抗高血圧薬のクラスに対する遵守の違いを体系的に評価し,定量化する.
- 抗高血圧薬のどのクラスが,患者のアデランスの改善または悪化と関連しているかを特定する.
主な方法:
- 2009年2月1日までの英語記事の体系的な文献検索.
- 薬の補充データを介して抗高血圧剤のアデレンスを測定した研究を含む.
- 逆変数加重ランダム効果モデルを用いたメタ分析により,危険比率をまとめました.
主要な成果:
- プールの平均アデレンス値は,β阻害薬の28%からアニオテンシンII受容体阻害薬の65%まででした.
- ACE阻害剤,CCB,利尿剤,ベータ阻害剤と比較して,アンジオテンシンII受容体阻害剤の固執度が高いことが観察されました.
- 出版バイアスを考慮すると,特定の薬剤クラスの比較では,従順性の有意な差はもはや観察されませんでした.
結論:
- 抗高血圧薬の服薬順守には,臨床環境における異なる薬剤クラスにおいて,著しい差異がある.
- 利尿剤とベータブロッカーは,最も低いアデレンス率を示したが,アニオテンシンII受容体ブロッカーのACE阻害剤は最も高い.
- 薬の全般的な服薬順守は,研究されたすべての抗高血圧薬のクラスで最適以下であった.
関連する概念動画
Antihypertensive Drugs: Action of β1 Blockers
2.2K
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.2K
Antihypertensive Drugs: Types of β-Blockers
2.0K
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
2.0K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.7K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K
Antihypertensive Drugs: Direct Renin Inhibitors
1.9K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.9K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
2.3K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.3K
Hypertension IV: Drug Therapy and Lifestyle Modifications
1.0K
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
1.0K


